Q32 Bio Provides Bempikibart Program Update, Including Next Steps for Advancing Alopecia Areata Development Program PR Newswire WALTHAM, Mass., Dec. 10, 2024 -- SIGNAL-AA demonstrated encouraging...
Q32 Bio Reports Third Quarter 2024 Financial Results and Provides Corporate Update PR Newswire WALTHAM, Mass., Nov. 7, 2024 -- Bempikibart Phase 2 topline results in atopic dermatitis (AD) and...
Q32 Bio to Participate in Guggenheim's Inaugural Healthcare Innovation Conference PR Newswire WALTHAM, Mass., Nov. 5, 2024 WALTHAM, Mass., Nov. 5, 2024 /PRNewswire/ -- Q32 Bio Inc. (Nasdaq: QTTB...
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.16 | 4.95356037152 | 3.23 | 3.5 | 3.02 | 175508 | 3.29349549 | CS |
4 | 0.12 | 3.66972477064 | 3.27 | 4.1499 | 2.99 | 318824 | 3.4463009 | CS |
12 | -43.14 | -92.7143778208 | 46.53 | 51.2569 | 2.99 | 384934 | 8.6067355 | CS |
26 | -25.87 | -88.4142173616 | 29.26 | 53.79 | 2.99 | 227421 | 17.60622498 | CS |
52 | -12.85 | -79.1256157635 | 16.24 | 53.79 | 2.99 | 163772 | 18.37017476 | CS |
156 | -12.85 | -79.1256157635 | 16.24 | 53.79 | 2.99 | 163772 | 18.37017476 | CS |
260 | -12.85 | -79.1256157635 | 16.24 | 53.79 | 2.99 | 163772 | 18.37017476 | CS |
Aucune Discussion Trouvée |
Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales